Episurf Medical entered into an agreement of SEK 1.5 million (~USD $0.2 million) for out-licensing of the µiFidelity® software platform.
µiFidelity is the communication and distribution arm of Episurf Medical’s orthopedic product line to treat articular cartilage damage and underlying bone lesions, where medical imaging constitutes a central part.
With this transaction, Episurf is licensing its platform to a U.S.-based orthopedic company, which intends to establish its own communication and distribution platform based on µiFidelity.
Episurf Medical entered into an agreement of SEK 1.5 million (~USD $0.2 million) for out-licensing of the µiFidelity® software platform.
µiFidelity is the communication and distribution arm of Episurf Medical’s orthopedic product line to treat articular cartilage damage and underlying bone lesions, where medical imaging constitutes a central...
Episurf Medical entered into an agreement of SEK 1.5 million (~USD $0.2 million) for out-licensing of the µiFidelity® software platform.
µiFidelity is the communication and distribution arm of Episurf Medical’s orthopedic product line to treat articular cartilage damage and underlying bone lesions, where medical imaging constitutes a central part.
With this transaction, Episurf is licensing its platform to a U.S.-based orthopedic company, which intends to establish its own communication and distribution platform based on µiFidelity.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
